<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">

<pdf2xml>
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="0" size="22" family="Times" color="#000000"/>
	<fontspec id="1" size="8" family="Times" color="#000000"/>
	<fontspec id="2" size="7" family="Times" color="#000000"/>
<text top="26" left="55" width="517" height="27" font="0"><b>ENCODE DCC Antibody Validation Document</b></text>
<text top="77" left="48" width="81" height="12" font="1">Date of Submission</text>
<text top="347" left="39" width="41" height="12" font="1">Antibody </text>
<text top="359" left="39" width="52" height="12" font="1">Description: </text>
<text top="371" left="39" width="2" height="12" font="1"> </text>
<text top="485" left="84" width="61" height="12" font="1">Species Target</text>
<text top="521" left="84" width="90" height="12" font="1">Validation Method #1</text>
<text top="134" left="291" width="25" height="12" font="1">Email:</text>
<text top="134" left="48" width="27" height="12" font="1">Name:</text>
<text top="215" left="48" width="68" height="12" font="1">Antibody Name:</text>
<text top="215" left="300" width="29" height="12" font="1">Target:</text>
<text top="170" left="192" width="15" height="12" font="1">Lab</text>
<text top="249" left="183" width="44" height="12" font="1">Company/</text>
<text top="261" left="183" width="31" height="12" font="1">Source:</text>
<text top="485" left="300" width="53" height="12" font="1">Species Host</text>
<text top="300" left="336" width="50" height="12" font="1">Lot Number</text>
<text top="294" left="39" width="172" height="12" font="1">Catalog Number, database ID, laboratory </text>
<text top="306" left="39" width="2" height="12" font="1"> </text>
<text top="521" left="300" width="90" height="12" font="1">Validation Method #2</text>
<text top="555" left="84" width="50" height="12" font="1">Purification </text>
<text top="567" left="84" width="33" height="12" font="1">Method</text>
<text top="555" left="300" width="48" height="12" font="1">Polyclonal/ </text>
<text top="567" left="300" width="50" height="12" font="1">Monoclonal</text>
<text top="626" left="30" width="58" height="12" font="1">Reference (PI/</text>
<text top="638" left="30" width="49" height="12" font="1">Publication </text>
<text top="650" left="30" width="52" height="12" font="1">Information)</text>
<text top="674" left="28" width="294" height="12" font="1">Please complete the following for antibodies to histone modifications: </text>
<text top="687" left="28" width="205" height="11" font="2">if your specifications are not listed in the drop-down box,  </text>
<text top="697" left="28" width="155" height="11" font="2">please write-in the appropriate information</text>
<text top="728" left="30" width="59" height="12" font="1">Histone Name</text>
<text top="728" left="156" width="52" height="12" font="1">AA modified</text>
<text top="728" left="327" width="48" height="12" font="1">AA Position</text>
<text top="728" left="444" width="53" height="12" font="1">Modification</text>
<text top="419" left="39" width="29" height="12" font="1">Target </text>
<text top="431" left="39" width="52" height="12" font="1">Description: </text>
<text top="443" left="39" width="2" height="12" font="1"> </text>
<text top="599" left="165" width="51" height="12" font="1">Vendor URL:</text>
<text top="601" left="238" width="189" height="12" font="1">http://www.scbt.com/datasheet-372-nfkappa</text>
<text top="613" left="238" width="108" height="12" font="1">b-p65-c-20-antibody.html</text>
<text top="77" left="138" width="38" height="12" font="1">10/28/11</text>
<text top="340" left="95" width="271" height="12" font="1">epitope mapping at the C-terminus of NFκB p65 of human origin </text>
<text top="352" left="95" width="306" height="12" font="1">recommended for detection of NFκB p65 of mouse, rat and human origin </text>
<text top="364" left="95" width="314" height="12" font="1">NOTE: WE PRESENT DATA HERE ON USE IN HUMAN AND MOUSE CELL LINES</text>
<text top="484" left="150" width="31" height="12" font="1">Human</text>
<text top="520" left="178" width="89" height="12" font="2">Immunoprecipitation</text>
<text top="134" left="326" width="92" height="12" font="1">sglandt@stanford.edu</text>
<text top="134" left="83" width="61" height="12" font="1">Stephen Landt</text>
<text top="214" left="121" width="139" height="12" font="1">NFκB p65 (C-20) Antibody: sc-372</text>
<text top="214" left="339" width="157" height="12" font="1">NFKB p65/ RELA (EntrezGene ID 5970)</text>
<text top="170" left="230" width="29" height="12" font="1">Snyder</text>
<text top="255" left="239" width="107" height="12" font="1">Santa Cruz Biotechnology</text>
<text top="484" left="361" width="27" height="12" font="1">Rabbit</text>
<text top="300" left="395" width="27" height="12" font="1">A2298</text>
<text top="300" left="215" width="27" height="12" font="1">sc-372</text>
<text top="520" left="395" width="73" height="12" font="2">Motif Enrichment</text>
<text top="561" left="141" width="30" height="12" font="2">Affinity</text>
<text top="561" left="356" width="43" height="12" font="2">Polyclonal</text>
<text top="412" left="95" width="445" height="12" font="1">NFKB1 (MIM 164011) or NFKB2 (MIM 164012) is bound to REL (MIM 164910), RELA, or RELB (MIM 604758) to </text>
<text top="424" left="95" width="444" height="12" font="1">form the NFKB complex. The p50 (NFKB1)/p65 (RELA) heterodimer is the most abundant form of NFKB. The </text>
<text top="436" left="95" width="424" height="12" font="1">NFKB complex is inhibited by I-kappa-B proteins (NFKBIA, MIM 164008 or NFKBIB, MIM 604495), which </text>
<text top="448" left="95" width="416" height="12" font="1">inactivate NFKB by trapping it in the cytoplasm. Phosphorylation of serine residues on the I-kappa-B </text>
<text top="460" left="95" width="410" height="12" font="1">proteins by kinases (IKBKA, MIM 600664, or IKBKB, MIM 603258) marks them for destruction via the </text>
<text top="472" left="95" width="414" height="12" font="1">ubiquitination pathway, thereby allowing activation of the NFKB complex. Activated NFKB complex </text>
<text top="484" left="95" width="427" height="12" font="1">translocates into the nucleus and binds DNA at kappa-B-binding motifs such as 5-prime GGGRNNYYCC </text>
<text top="496" left="95" width="421" height="12" font="1">3-prime or 5-prime HGGARNYYCC 3-prime (where H is A, C, or T; R is an A or G purine; and Y is a C or T </text>
<text top="508" left="95" width="132" height="12" font="1">pyrimidine).(supplied by OMIM)</text>
</page>
<page number="2" position="absolute" top="0" left="0" height="792" width="612">
<text top="146" left="52" width="57" height="12" font="1">Validation #1 </text>
<text top="158" left="52" width="34" height="12" font="1">Analysis</text>
<text top="661" left="50" width="143" height="12" font="1">Insert Validation Image (click here)</text>
<text top="43" left="125" width="419" height="12" font="1">Comment: In both human GM12878 cells and murine CH12 and MEL cells, a unique band of ~65kD is </text>
<text top="55" left="125" width="393" height="12" font="1">detected by Western blotting with sc-372 and immunoprecipitated efficiently.  Based on these </text>
<text top="67" left="125" width="237" height="12" font="1">observations, this antibody meets this ENCODE criterion. </text>
</page>
<page number="3" position="absolute" top="0" left="0" height="612" width="792">
	<fontspec id="3" size="16" family="Times" color="#000000"/>
	<fontspec id="4" size="10" family="Times" color="#000000"/>
	<fontspec id="5" size="16" family="Times" color="#000000"/>
<text top="150" left="75" width="655" height="12" font="1">Immunoprecipita-ons  using sc‐372 were carried out in GM12878 cells treated with TNFa (6 hrs), murine CH12 cells and murine MEL cells.  NE= nuclear lysate, S= </text>
<text top="162" left="75" width="649" height="12" font="1">supernatant from immunoprecipita-on with sc‐372, IP= bound material from immunoprecipita-on with sc‐372, IgG= bound material from immunoprecipita-on </text>
<text top="174" left="75" width="655" height="12" font="1">with control IgG.  Arrows indicate band consistent with the expected size of NFKB p65.  Bands indicated by * in GM12878 immunoprecipita-on are IgG heavy and </text>
<text top="186" left="75" width="601" height="12" font="1">light chains.  These bands are absent from CH12 and MEL immunoprecipita-ons because an-body was crosslinked to Protein A beads prior to use in </text>
<text top="198" left="75" width="250" height="12" font="1">immunoprecipita-on.  Molecular weights are indicated in kD. </text>
<text top="83" left="103" width="547" height="22" font="3"><b>Valida&amp;on 1:  Immunoblot/immunoprecipita&amp;on with sc‐372 (NFKB p65 ) </b></text>
<text top="336" left="625" width="21" height="15" font="4"><b>130 </b></text>
<text top="358" left="625" width="21" height="15" font="4"><b>100 </b></text>
<text top="374" left="628" width="15" height="15" font="4"><b>70 </b></text>
<text top="395" left="628" width="15" height="15" font="4"><b>50 </b></text>
<text top="332" left="410" width="21" height="15" font="4"><b>130 </b></text>
<text top="354" left="410" width="21" height="15" font="4"><b>100 </b></text>
<text top="370" left="413" width="15" height="15" font="4"><b>70 </b></text>
<text top="391" left="413" width="15" height="15" font="4"><b>50 </b></text>
<text top="263" left="459" width="43" height="22" font="3"><b>CH12 </b></text>
<text top="263" left="564" width="36" height="22" font="3"><b>MEL </b></text>
<text top="274" left="172" width="142" height="23" font="3"><b>GM12878 (+TNF</b>α<b>) </b></text>
<text top="304" left="202" width="70" height="15" font="4"><b>NE  S  IP    IgG </b></text>
<text top="336" left="181" width="21" height="15" font="4"><b>150 </b></text>
<text top="351" left="181" width="21" height="15" font="4"><b>100 </b></text>
<text top="362" left="184" width="15" height="15" font="4"><b>75 </b></text>
<text top="381" left="184" width="15" height="15" font="4"><b>50 </b></text>
<text top="415" left="184" width="15" height="15" font="4"><b>25 </b></text>
<text top="403" left="250" width="42" height="22" font="5">*  * </text>
<text top="375" left="250" width="13" height="22" font="5">* </text>
</page>
<page number="4" position="absolute" top="0" left="0" height="792" width="612">
<text top="159" left="57" width="57" height="12" font="1">Validation #2 </text>
<text top="171" left="57" width="34" height="12" font="1">Analysis</text>
<text top="643" left="54" width="145" height="12" font="1">Insert Validation Image (Click here)</text>
<text top="698" left="268" width="68" height="10" font="1">Submit by Email</text>
<text top="43" left="130" width="386" height="12" font="1">Calculations were done by Pouya Kheradpour using a collection of known motifs available at </text>
<text top="55" left="130" width="422" height="12" font="1">http://www.broadinstitute.org/%7Epouyak/motif-disc/human/.   Table 1 shows the fold-enrichments, </text>
<text top="67" left="130" width="411" height="12" font="1">enrichment p-values and fraction of peaks which contain the motif.  The motif which produced the </text>
<text top="79" left="130" width="408" height="12" font="1">largest value for each criterion is shown in Table 1.  Note that while the maximally enriched motifs </text>
<text top="91" left="130" width="418" height="12" font="1">may differ from the motif with the highest enrichment p-values and the most represented motif, the </text>
<text top="103" left="130" width="341" height="12" font="1">motifs are highly similar (Figure 1) and thus all values are similar between motifs.   </text>
<text top="115" left="130" width="2" height="12" font="1"> </text>
<text top="127" left="130" width="418" height="12" font="1">Motifs were identified using a matching stringency corresponding to 4-6 (6-mer). Peaks identified by </text>
<text top="139" left="130" width="375" height="12" font="1">IDR (1% cutoff) were used in the analysis and +/-50bp from peak centers were considered. </text>
<text top="152" left="130" width="400" height="12" font="1">Enrichments are for a given motif vs. a background consisting of +/- 50bp from the centers of all </text>
<text top="164" left="130" width="398" height="12" font="1">DnaseI hypersensitive peaks.  Repeat mask/simple repeats from UCSC and all gencode v7 exons </text>
<text top="176" left="130" width="421" height="12" font="1">(including non-protein coding genes) were excluded from the analysis.  Comparison to shuffle motifs </text>
<text top="188" left="130" width="380" height="12" font="1">were used to correct for compositional bias.  Enrichment is the corrected # of motifs in ChIP </text>
<text top="200" left="130" width="186" height="12" font="1">peaks/corrected # of motifs in DNaseI peaks. </text>
<text top="212" left="130" width="2" height="12" font="1"> </text>
<text top="224" left="130" width="408" height="12" font="1">The current ENCODE standard calls for &gt;4-fold enrichment and &gt;10% motif representation for this </text>
<text top="236" left="130" width="417" height="12" font="1">criteria to be used for validation.  The 11 NFKB datasets presented here exceed these thresholds and </text>
<text top="248" left="130" width="156" height="12" font="1">the antibody is considered validated. </text>
</page>
<page number="5" position="absolute" top="0" left="0" height="612" width="792">
	<fontspec id="6" size="10" family="Times" color="#000000"/>
	<fontspec id="7" size="14" family="Times" color="#000000"/>
	<fontspec id="8" size="14" family="Times" color="#000000"/>
	<fontspec id="9" size="8" family="Times" color="#000000"/>
	<fontspec id="10" size="12" family="Times" color="#000000"/>
	<fontspec id="11" size="11" family="Times" color="#000000"/>
<text top="281" left="163" width="485" height="15" font="4"><b>Figure 2.  </b>Mo#f consensus sequences and posi#on weight matrices for highly enriched NFKB mo#f.  </text>
<text top="277" left="648" width="4" height="20" font="7"> </text>
<text top="57" left="319" width="166" height="15" font="4"><b>Table 1.  </b>NFKB mo#f enrichment.  </text>
<text top="53" left="485" width="4" height="20" font="7"> </text>
<text top="87" left="113" width="39" height="11" font="2">Cell Line</text>
<text top="87" left="213" width="109" height="11" font="2">Motif Enrichment (log2)</text>
<text top="87" left="380" width="131" height="11" font="2">Enrichment p-value (-log10)</text>
<text top="87" left="549" width="156" height="11" font="2">Fraction of peaks containing motif</text>
<text top="101" left="95" width="74" height="11" font="2">NFKB_GM10847</text>
<text top="101" left="195" width="145" height="11" font="2">3.38588  (NF-kappaB_known1)</text>
<text top="101" left="373" width="145" height="11" font="2">1383.46  (NF-kappaB_known1)</text>
<text top="101" left="552" width="150" height="11" font="2">0.410202  (NF-kappaB_known5)</text>
<text top="114" left="95" width="74" height="11" font="2">NFKB_GM12878</text>
<text top="114" left="195" width="145" height="11" font="2">3.40875  (NF-kappaB_known1)</text>
<text top="114" left="373" width="145" height="11" font="2">1847.76  (NF-kappaB_known1)</text>
<text top="114" left="552" width="150" height="11" font="2">0.331598  (NF-kappaB_known5)</text>
<text top="127" left="95" width="74" height="11" font="2">NFKB_GM12878</text>
<text top="127" left="195" width="145" height="11" font="2">3.50712  (NF-kappaB_known1)</text>
<text top="127" left="373" width="145" height="11" font="2">1953.32  (NF-kappaB_known1)</text>
<text top="127" left="552" width="150" height="11" font="2">0.336786  (NF-kappaB_known5)</text>
<text top="140" left="95" width="74" height="11" font="2">NFKB_GM12891</text>
<text top="140" left="195" width="145" height="11" font="2">2.98034  (NF-kappaB_known1)</text>
<text top="140" left="373" width="145" height="11" font="2">3158.79  (NF-kappaB_known1)</text>
<text top="140" left="552" width="150" height="11" font="2">0.311203  (NF-kappaB_known5)</text>
<text top="153" left="95" width="74" height="11" font="2">NFKB_GM12892</text>
<text top="153" left="195" width="145" height="11" font="2">3.58808  (NF-kappaB_known1)</text>
<text top="153" left="376" width="139" height="11" font="2">1025.9  (NF-kappaB_known1)</text>
<text top="153" left="552" width="150" height="11" font="2">0.485587  (NF-kappaB_known5)</text>
<text top="165" left="95" width="74" height="11" font="2">NFKB_GM15510</text>
<text top="165" left="198" width="139" height="11" font="2">2.1634  (NF-kappaB_known5)</text>
<text top="165" left="373" width="145" height="11" font="2">1034.71  (NF-kappaB_known5)</text>
<text top="165" left="552" width="150" height="11" font="2">0.206633  (NF-kappaB_known5)</text>
<text top="178" left="95" width="74" height="11" font="2">NFKB_GM18505</text>
<text top="178" left="195" width="145" height="11" font="2">3.48915  (NF-kappaB_known1)</text>
<text top="178" left="376" width="139" height="11" font="2">1451.5  (NF-kappaB_known1)</text>
<text top="178" left="552" width="150" height="11" font="2">0.383419  (NF-kappaB_known5)</text>
<text top="191" left="95" width="74" height="11" font="2">NFKB_GM18526</text>
<text top="191" left="198" width="139" height="11" font="2">3.9191  (NF-kappaB_known1)</text>
<text top="191" left="373" width="145" height="11" font="2">446.627  (NF-kappaB_known1)</text>
<text top="191" left="552" width="150" height="11" font="2">0.642955  (NF-kappaB_known5)</text>
<text top="204" left="95" width="74" height="11" font="2">NFKB_GM18951</text>
<text top="204" left="195" width="145" height="11" font="2">2.63442  (NF-kappaB_known1)</text>
<text top="204" left="373" width="145" height="11" font="2">1560.49  (NF-kappaB_known1)</text>
<text top="204" left="552" width="150" height="11" font="2">0.265892  (NF-kappaB_known5)</text>
<text top="217" left="95" width="74" height="11" font="2">NFKB_GM19099</text>
<text top="217" left="195" width="145" height="11" font="2">3.44391  (NF-kappaB_known1)</text>
<text top="217" left="376" width="139" height="11" font="2">1719.2  (NF-kappaB_known1)</text>
<text top="217" left="552" width="150" height="11" font="2">0.449522  (NF-kappaB_known5)</text>
<text top="230" left="95" width="74" height="11" font="2">NFKB_GM19193</text>
<text top="230" left="195" width="145" height="11" font="2">3.49646  (NF-kappaB_known1)</text>
<text top="230" left="373" width="145" height="11" font="2">1175.42  (NF-kappaB_known1)</text>
<text top="230" left="552" width="150" height="11" font="2">0.477133  (NF-kappaB_known5)</text>
<text top="315" left="158" width="101" height="20" font="8"><b>NFKB_known1 </b></text>
<text top="415" left="69" width="40" height="12" font="9"><b>Posi9on/ </b></text>
<text top="427" left="66" width="46" height="12" font="9"><b>Consensus </b></text>
<text top="416" left="156" width="12" height="17" font="10"><b>A </b></text>
<text top="416" left="203" width="11" height="17" font="10"><b>C </b></text>
<text top="416" left="249" width="12" height="17" font="10"><b>G </b></text>
<text top="416" left="296" width="10" height="17" font="10"><b>T </b></text>
<text top="405" left="128" width="281" height="9" font="2">&gt;NF-kappaB_known1 NF-kappaB-(p50)_transfac_M00051 +</text>
<text top="415" left="128" width="5" height="9" font="2"></text>
<text top="426" left="128" width="5" height="9" font="2"></text>
<text top="437" left="128" width="205" height="9" font="2">G 0.000000 0.000000 1.000000 0.000000</text>
<text top="448" left="128" width="205" height="9" font="2">G 0.000000 0.000000 1.000000 0.000000</text>
<text top="458" left="128" width="205" height="9" font="2">G 0.000000 0.000000 1.000000 0.000000</text>
<text top="469" left="128" width="205" height="9" font="2">G 0.111111 0.000000 0.888889 0.000000</text>
<text top="480" left="128" width="205" height="9" font="2">A 0.888888 0.055556 0.000000 0.055556</text>
<text top="491" left="128" width="205" height="9" font="2">K 0.000000 0.000000 0.166667 0.833333</text>
<text top="502" left="128" width="205" height="9" font="2">Y 0.000000 0.388889 0.055556 0.555555</text>
<text top="513" left="128" width="205" height="9" font="2">C 0.000000 0.888889 0.000000 0.111111</text>
<text top="523" left="128" width="205" height="9" font="2">C 0.000000 1.000000 0.000000 0.000000</text>
<text top="534" left="128" width="200" height="9" font="2">C 0.000000 0.944444 0.055556 0.000000</text>
<text top="531" left="328" width="8" height="13" font="11"></text>
<text top="405" left="481" width="221" height="9" font="2">&gt;NF-kappaB_known5 RELA_jaspar_MA0107.1 +</text>
<text top="415" left="481" width="5" height="9" font="2"></text>
<text top="426" left="481" width="5" height="9" font="2"></text>
<text top="437" left="481" width="205" height="9" font="2">B 0.000000 0.222222 0.611111 0.166667</text>
<text top="448" left="481" width="205" height="9" font="2">G 0.000000 0.000000 0.944444 0.055556</text>
<text top="458" left="481" width="205" height="9" font="2">G 0.000000 0.000000 1.000000 0.000000</text>
<text top="469" left="481" width="205" height="9" font="2">R 0.611111 0.000000 0.388889 0.000000</text>
<text top="480" left="481" width="205" height="9" font="2">V 0.555555 0.166667 0.222222 0.055556</text>
<text top="491" left="481" width="205" height="9" font="2">T 0.111111 0.000000 0.000000 0.888889</text>
<text top="502" left="481" width="205" height="9" font="2">T 0.000000 0.000000 0.000000 1.000000</text>
<text top="513" left="481" width="205" height="9" font="2">T 0.000000 0.111111 0.000000 0.888889</text>
<text top="523" left="481" width="205" height="9" font="2">C 0.000000 1.000000 0.000000 0.000000</text>
<text top="534" left="481" width="200" height="9" font="2">C 0.000000 1.000000 0.000000 0.000000</text>
<text top="531" left="681" width="8" height="13" font="11"></text>
<text top="415" left="420" width="40" height="12" font="9"><b>Posi9on/ </b></text>
<text top="427" left="417" width="46" height="12" font="9"><b>Consensus </b></text>
<text top="417" left="507" width="12" height="17" font="10"><b>A </b></text>
<text top="417" left="554" width="11" height="17" font="10"><b>C </b></text>
<text top="417" left="600" width="12" height="17" font="10"><b>G </b></text>
<text top="417" left="647" width="10" height="17" font="10"><b>T </b></text>
<text top="315" left="522" width="101" height="20" font="8"><b>NFKB_known5 </b></text>
</page>
</pdf2xml>
